This new 'ultraportable' outdoor speaker is on sale for under $60
Why you should buy the Ultimate Ears Miniroll speaker
One of the great things about recent reviews is that you don't have to filter them through the context of time. Our Ultimate Ears Miniroll speaker review was released just days ago. If you are considering picking up this deal, you can just read it directly for the absolute best look at the speaker, then come back and get this deal. The only thing the review won't prepare you for is that this deal is only on the black version of the speaker and not the playful blue edition that Simon is using.
If you're not up for reading the review in totality, that's fine too. The Ultimate Ears Miniroll speaker is, despite its soft an unimposing appearance, a tough speaker that you can throw in your bag and go. It won't take damage from a dip in the pool (but it will sink, so keep it on the shallow end!) and has great sound for the size. If you want more sound, you can chain up multiple Minirolls together to sync up your music — which makes this an excellent gift to buy for a father/child duo in your life, or as a treat for you and a gift for dad.
Pick up an Ultimate Ears Miniroll for just $59 while this deal lasts. That's $21 off of the usual $80 and a great deal for a product that's so new. If it doesn't pick up your interests, there are always other speaker deals to check out.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Masimo sues US Customs over approval of Apple Watch imports
By Blake Brittain WASHINGTON (Reuters) -Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies. Masimo said in the lawsuit in Washington, D.C., federal court that Customs improperly determined that Apple can import watches with pulse oximetry technology, reversing its own decision from last year without notifying Masimo. Masimo told the court that it learned of the agency's August 1 decision only after Apple announced it would reintroduce blood-oxygen reading to its watches last week. Spokespeople for Apple and Customs did not immediately respond to requests for comment. A Masimo spokesperson declined to comment. Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in its Apple Watches. Masimo has separately sued Apple for patent infringement and trade secret theft in ongoing federal court cases. Masimo convinced the U.S. International Trade Commission to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023 based on a determination that Apple's technology for reading blood oxygen levels infringed Masimo's patents. Apple has continued to sell Customs-approved redesigned watches without pulse oximetry since the ITC's decision. Apple said on Aug. 14 that it would reintroduce its smartwatches' blood-oxygen reading capabilities with approval from Customs. Masimo said the agency's decision to approve the watches without input from Masimo or any "meaningful justification" deprived the company of its rights. "CBP's function is to enforce ITC exclusion orders, not to create loopholes that render them ineffective," Masimo said. Masimo asked the Washington court to halt the agency's ruling and continue to block Apple from selling watches with the blood-oxygen feature.
Yahoo
23 minutes ago
- Yahoo
Bloom Energy (BE) Stock in Focus: Jefferies Sticks With Hold Amid Growth Catalysts
Bloom Energy Corporation (NYSE:) is one of the On August 18, Jefferies analyst Lloyd Byrne reiterated a Hold rating on the stock with a $24.00 price target. The firm quoted several potential catalysts working in favor of the stock, including a letter from PJM Interconnection, the CEO's Bloomberg interview, and potential read-throughs from Crowdstrike earnings. It also estimated that investors may be expecting around 1GW of sales in 2027. The firm considers this target a possibility due to Bloom Energy's capacity expansion to 2GW by year-end 2026. 'We estimate the buyside could be baking in ~1GW of sales in '27. With BE expanding capacity to 2GW (1.3GW for product, rest for service) by YE26, hitting that target is possible. However, cadence and timing of deals matter, and we question whether investors are getting ahead of themselves. With BE +20% last week: expectations are ramping with DC deal & efforts by PJM to require new supply with new load. At current levels, we try to determine implied volumes. The stock is currently trading at ~22x '27E EBITDA of $526mn. The median multiple for data center / hyperscalers adjacent cos is ~18x (Ex – 2). To justify a more 'normalized' multiple, investors might be baking much higher EBITDA growth vs sell-side cons.' Bloom Energy Corporation (NYSE:BE) develops solid-oxide fuel cell systems for on-site power generation, helping meet the growing energy demands of AI data centers. While we acknowledge the potential of BE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
23 minutes ago
- Yahoo
Tesla (TSLA) Stock: Barclays Reiterates Equal Weight, Cites Robotaxi Permit Delays
Tesla, Inc. (NASDAQ:TSLA) is one the . On August 18, Barclays reiterated the stock as 'Equal Weight' stating that it sees a 'lengthy' permitting process for Tesla's robotaxi. 'The process for 'real' autonomous Robotaxi in CA will likely be lengthy, as Tesla must apply for and receive a number of permits prior to offering paid, driverless services; moreover, media reports indicate that Tesla's engagement with California regulators has been more limited than people realize, with Tesla Robotaxi pitched for now in a more limited way than people understand.' Pixabay/Public Domain Analysts on Wall Street currently have a consensus 'Buy' rating on the stock. The average price target of $329 implies a 1.8% upside; however, the Street-high target of $500 implies an upside of 49.2%. Tesla, Inc. (NASDAQ:TSLA) is an automotive and clean energy company that leverages advanced artificial intelligence in its autonomous driving technology and robotics initiatives. While we acknowledge the potential of TSLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
